No recent announcements
| 7 Jul 2022 | Annual Report and Accounts (to 2021-12-31) | |
| 15 Jul 2021 | Annual Report and Accounts (to 2020-12-31) |
| 17 Jan 2023 | Understanding the significance of 230MeV | |
| 29 Sept 2022 | Major milestone achieved | |
| 14 Mar 2022 | LIGHT: regulatory update | |
| 15 Nov 2021 | On the home straight | |
| 12 Aug 2021 | Funded to completion | |
| 15 Dec 2020 | Leveraging the modularity of LIGHT | |
| 7 Oct 2020 | Progress towards commissioning of first LIGHT | |
| 2 Jul 2020 | Funded through to clinical events |
Advanced Oncotherapy is a company based in the UK, with branches in London, Geneva, The Netherlands, and the USA. They specialize in particle therapy using protons, utilizing cutting-edge technology.
| 7 Jul 2022 | Annual Report and Accounts (to 2021-12-31) | |
| 15 Jul 2021 | Annual Report and Accounts (to 2020-12-31) |
| 17 Jan 2023 | Understanding the significance of 230MeV | |
| 29 Sept 2022 | Major milestone achieved | |
| 14 Mar 2022 | LIGHT: regulatory update | |
| 15 Nov 2021 | On the home straight | |
| 12 Aug 2021 | Funded to completion | |
| 15 Dec 2020 | Leveraging the modularity of LIGHT | |
| 7 Oct 2020 | Progress towards commissioning of first LIGHT | |
| 2 Jul 2020 | Funded through to clinical events |
Advanced Oncotherapy is a company based in the UK, with branches in London, Geneva, The Netherlands, and the USA. They specialize in particle therapy using protons, utilizing cutting-edge technology.